News results: "Acomplia" |
|
 |
|
Pfizer, Sanofi-Avensis End Studies on Diet Drugs
Pfizer Inc.and Sanofi-Aventis on Wednesday separately announced their
decision to cancel further...
|
Pfizer Halts Phase III Trial On Obesity Drug Over US Rejection Fears
Pfizer Inc., the world’s largest drugmaker, on Wednesday
said it abandoned an obesity drug known...
|
Anti-Obesity Drug Pulled From European Markets
On
Thursday, the French pharmaceutical company Sanofi-Aventis halted the
sales of their...
|
Sales of Sanofi’s Anti-Obesity Drug Acomplia Suspended In Europe
Warnings about Sanofi-Aventis’ anti-obesity
rimonabant (Acomplia) had always accompanied the drug,...
|
Merck’s Discontinuation On Taranabant Development
Merck & Co. has decided to bring to an end the development the experimental obesity drug...
|
Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant
Merck & Co. on Thursday announced its decision
to cancel further investigation into its...
|
Farewell To Development Of Obesity Drug Taranabant
Merck halted the research of the experimental obesity drug taranabant because of the dangerous side...
|
Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects
Merck Research Laboratories developed a new drug, called
taranabant, which helped people shed...
|
Sanofi-Aventis SA Faces Challenges on Acomplia
Sanofi-Aventis SA faces new challenges
on its obesity drug Acomplia, after alarming studies were...
|
EU Health Officials Warn About Weight-Loss Drug
A European health watchdog has warned that taking weight-loss drug Acomplia bears a risk of...
|
FDA Warns About Acomplia, The Weight Loss Pill
A diet-pill developed by Sanofi-Aventis may trigger suicidal
behavior and suicidal behavior and...
|
|
 |
|
| Photos Gallery |
|
|
 |
|